Skip to main content
Log in

Prilocaine elimination by isolated perfused rat lung and liver

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

Prilocaine is assumed to undergo significant elimination by extrahepatic organs and to differ in this respect from other commonly used local anaesthetics. In order to clarify whether the lung may play an important role as a site of elimination of prilocaine, the kinetic parameters were studied in isolated perfused rat lungs and were compared to those of isolated livers. Furthermore, the structurally related compounds bupivacaine and mepivacaine were also investigated in this system. Prilocaine was dispersed into a relatively large apparent distribution volume in perfused rat lung (139 ml versus 97 ml in controls). In single-pass perfused lungs the observed maximum of concentration was decreased by about 60% compared to controls. The mean residence time was prolonged by about 40%. These observations suggest that prilocaine is substantially retained by rat lung and that this effect occurs particularly during first-pass.

However, the ability of rat lung to degrade prilocaine was relatively low. The clearance values were about 0.3 ml/min equal to about 20% of the hepatic capacity calculated per g of tissue. Thus it must be assumed that prilocaine is only transiently retained by the lung and will gain systemic availability later on. In rat lungs the kinetics of prilocaine elimination were not substantially different from those of bupivacaine and mepivacaine (16 and 12%). These observations do not support the assumption that especially prilocaine undergoes extrahepatic elimination.

For low (2 μg/ml) and intermediate (10 μg/ml) drug concentrations isolated rat liver exhibited clearance values close to the perfusion flow rate. Accordingly, prilocaine was removed from the perfusion medium of isolated livers already during first-pass. At very high concentrations of 100 μg/ml, the clearance dropped to about half of the control values. Thus under these conditions approximately half of the dose escaped first-pass extraction which is probably caused by saturated metabolic clearance. Such an effect was not observed for bupivacaine and mepivacaine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Akerman B, Astrom A, Ross S, Telc A (1966) Studies on the absorption, distribution and metabolism of labelled prilocaine and lidocaine in some animal species. Acta Pharmacol Toxicol 24:389–403

    Google Scholar 

  • Arthur GR (1987) Pharmacokinetics of local anesthetics. In: Strichartz GR (ed) Local anesthetics. Handbook of experimental pharmacology, vol. 81, Springer, Berlin Heidelberg New York, pp 165–186

    Google Scholar 

  • Arthur GR, Scott DHT, Boyes RN, Scott DB (1979) Pharmacokinetic and clinical pharmacological studies with mepivacaine and prilocaine. Br J Anaesth 51:481–485

    Google Scholar 

  • Bachmann B, Biscoping J, Sinnung E, Hempelmann G (1990) Protein binding of prilocaine in human plasma: influence of concentration, pH and temperature. Acta Anaesth Scand 34:311–314

    Google Scholar 

  • Bargetzi MJ, Aoyama T, Gonzalez FJ, Meyer UA (1989) Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4. Clin Pharmacol Ther 46:521–527

    Google Scholar 

  • Burm AGL (1989) Clinical pharmacokinetics of epidural and spinal anaesthesia. Clin Pharmacokin 16:283–311

    Google Scholar 

  • Foth H, Kietzmann D, Geng WP, Ebke M, Michaelis HC, Schroder T, Hering JP (1991) Pulmonary uptake of prilocaine, mepivacaine and bupivacaine. Naunyn-Schmiedeberg's Arch Pharmacol 343:R 5

    Google Scholar 

  • Gibaldi M, Koup JR (1981) Pharmacokinetic concepts. Drug binding, apparent volume of distribution and clearance. Eur J Clin Pharmacol 20:299–305

    Google Scholar 

  • Gibaldi M, Perrier D (1982) In: Gibaldi M, Perrier D (eds) Pharmacokinetics, 2nd edn. Marcel Dekker, New York, pp 45–50

    Google Scholar 

  • Hems R, Ross BD, Krebs HA (1966) Gluconeogenesis in the perfused rat liver. Biochem J 101:2203–2206

    Google Scholar 

  • Michaelis HC, Geng WP, Foth H, Kahl GF (1990) Sensitive determination of bupivacaine in human plasma by high performance liquid chromatography. J Chromatogr 527:201–207

    Google Scholar 

  • Miller LL, Bly CG, Watson ML, Bale WF (1951) The dominant role of liver in plasma protein synthesis. J Exp Med 94:431–453

    Google Scholar 

  • Moore DC, Crawford RD, Scurlock JE (1980) Severe hypoxia and acidosis following local anaesthetic-induced convulsions. Anaesthesiology 52:259–260

    Google Scholar 

  • Oda Y, Imaoka S, Nakahira Y, Asada A, Fujimori M, Fujita S, Funae Y (1989) Metabolism of lidocaine by purified rat liver microsomal cytochromc P-450 isozymes. Biochem Pharmacol 24:4439–4444

    Google Scholar 

  • Roberts MS, Fraser S, Wagner A, McLeod J (1990) Residence time distributions of solutes in the perfused rat liver using a dispersion model of hepatic elimination: I. Effect of changes in perfusate flow and albumin concentration on sucrose and taurocholate. J Pharmacokin Biopharm 18:209–234

    Google Scholar 

  • Roerig DL, Kotrly KL, Vucins EJ, Ahlfs SB, Dawson CA, Kampine JP (1987) First-pass uptake of fentanyl, meperidine, and morphine in the human lung. Anesthesiology 69:466–472

    Google Scholar 

  • Roerig DL, Kotrly KJ, Dawson CA, Ahlfs SB, Gualtieri JF, Kampine JP (1989) First-pass uptake of verapamil, diazepam, and thiopental in the human lung. Anesth Analg 67:461–466

    Google Scholar 

  • Ross BD (1972) Isolated perfused lung. In: Ross BD (ed) Perfusion techniques in biochemistry. A laboratory manual in the use of isolated perfused organs in biochemical experimentation. Clarendon Press, Oxford, pp 439–455

    Google Scholar 

  • Rothstein P, Cole JS, Pitt BR (1987) Pulmonary extraction of [3H]bupivacaine: Modification by dose, propranolol and interaction with [14C]5-hydroxytryptamine. J Pharmacol Exp Ther 240:410–414

    Google Scholar 

  • Scott DB (1986) Toxic effects of local anaesthetic agents on the central nervous system. Br J Anaesth 58:732–735

    CAS  PubMed  Google Scholar 

  • Tucker GT (1986) Pharmacokinetics of local anaesthetics. Br J Anaesth 58:717–731

    Google Scholar 

  • Tucker GT, Boas RA (1971) Pharmacokinetic aspects of intravenous regional anesthesia. Anesthesiology 34:538–549

    Google Scholar 

  • Tucker GT, Mather LE (1988) Properties, absorption and disposition of local anesthetic agents. In: Cousins MJ, Bridenbaugh PO (eds) Neural blockade in clinical anesthesia and management of pain, 2nd edn. Philadelphia, Lippincott, pp 47–110

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Part of the doctoral thesis of Markus Ebke, Medical Faculty of the University of Göttingen

Rights and permissions

Reprints and permissions

About this article

Cite this article

Geng, W.P., Ebke, M. & Foth, H. Prilocaine elimination by isolated perfused rat lung and liver. Naunyn-Schmiedeberg's Arch Pharmacol 351, 93–98 (1995). https://doi.org/10.1007/BF00169069

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00169069

Key words

Navigation